Pharmacology for Nurses · Drugs to Treat Myasthenia Gravis and Alzheimer’s Disease
Introduction to Myasthenia Gravis
On this page 9 sections
In 30 seconds
Myasthenia gravis (MG) is a chronic autoimmune disorder in which the body's immune system attacks the connection between nerves and muscles — the Neuromuscular junction (NMJ) The synapse where a motor neuron signals a muscle fiber Full entry →. In the most common form, antibodies bind to the nicotinic acetylcholine receptors on the muscle side of the junction. With fewer working receptors, the nerve's chemical message (acetylcholine) cannot reliably trigger muscle contraction. The result is skeletal muscle weakness that worsens with repeated use and improves with rest — the hallmark of the disease.
MG can affect any skeletal muscle but favors certain groups: the eye muscles (drooping eyelids, double vision), the face, throat, and tongue (slurred speech, trouble swallowing), and the limb and respiratory muscles. It varies greatly from person to person — some have only eye symptoms, others severe generalized weakness. It is treatable, and understanding its mechanism is the key to understanding every drug used for it.
Why this matters
MG matters to nurses for three reasons. It is the classic example of a disease where pharmacology makes sense only through physiology: the drugs boost the acetylcholine signal the immune system has partially destroyed. It can be life-threatening — weakness of the breathing muscles can progress to myasthenic crisis, a medical emergency requiring respiratory support. And the drugs used to treat it can themselves cause dangerous effects if overdosed, so people with MG need teaching about medication timing, crisis warning signs, and triggers. For exams, MG is high-yield: its mechanism, hallmark symptoms, and the cholinergic/myasthenic crisis distinction appear frequently. Person-first language matters here as everywhere: these are people living with myasthenia gravis, not "myasthenics."
The college version
Core Concepts
The neuromuscular junction: how muscle contraction normally happens
A motor neuron ends at the NMJ, a specialized synapse where the neuron meets a muscle fiber. When the neuron fires, it releases Acetylcholine (ACh) The neurotransmitter that triggers skeletal muscle contraction Full entry →, which binds to nicotinic acetylcholine receptors on the muscle membrane; enough activation triggers contraction. The enzyme acetylcholinesterase (AChE) then quickly breaks down ACh so the muscle can relax. Every step — release, binding, breakdown — is a potential drug target, which is why this chapter pairs the disease with its pharmacology.
The autoimmune attack
In MG, antibodies against the person's own ACh receptors (AChR) bind to them and cause destruction or blockade. With fewer functional receptors, a normal amount of ACh produces a weaker-than-normal response. Because repeated nerve firing releases ACh that cannot all be captured, weakness accumulates with use — a phenomenon called Fatigability Weakness that worsens with use and improves with rest Full entry →. Rest allows partial recovery, so symptoms fluctuate through the day. A smaller proportion of people have antibodies against other NMJ proteins (for example, muscle-specific kinase, MuSK); the antibody type affects diagnosis and treatment, and not everyone with MG has a detectable antibody.
Recognizing the disease: hallmark symptoms
Symptoms follow the muscle groups involved, and onset is often gradual:
- Ocular — the most common first presentation: ptosis (drooping eyelid) and diplopia (double vision).
- Bulbar — difficulty chewing, slurred or nasal speech (dysarthria), and trouble swallowing (dysphagia).
- Limb and axial — proximal muscles (shoulders, hips) more than hands and feet; difficulty raising the arms or climbing stairs.
- Respiratory — the most dangerous: breathlessness with activity or a weak cough signals impending crisis.
The key diagnostic clue is fluctuation: weakness worse after exertion and better after rest, often worse later in the day.
Myasthenic crisis vs. cholinergic crisis
Diagnosis is clinical plus confirmatory testing: antibody blood tests, electrodiagnostic studies, and sometimes imaging of the thymus, which is abnormal in a substantial portion of people with MG. What nurses must know cold is the difference between two emergencies that both look like "sudden severe weakness":
- Myasthenic crisis — the disease itself flares (often triggered by infection, stress, surgery, or certain medications): weakness worsens, breathing fails, and the person needs more treatment and respiratory support.
- Cholinergic crisis — too much cholinergic medication overstimulates the junction: weakness occurs, but with muscarinic effects such as excessive salivation, tearing, sweating, diarrhea, and bradycardia.
The two are managed in opposite directions, so distinguishing them (by history, medication timing, and clinical signs, with expert assessment) is a core nursing safety concept.
Treatment overview (mechanisms only)
- Acetylcholinesterase inhibitors (cholinergic drugs) slow the breakdown of ACh, so more is available to bind the remaining receptors — symptomatic treatment, covered in the next topic.
- Immunosuppressive therapy reduces the autoimmune attack; dosing is individualized.
- Thymectomy (surgical removal of the thymus) may improve outcomes in selected people.
- In crisis, plasmapheresis (plasma exchange) or IVIG may be used under specialist direction.
No doses or schedules are given here: all treatment must be verified against current references, the formulary, and prescriber orders.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| Myasthenic crisis | Cholinergic crisis | Crisis = disease flare needing more cholinergic treatment; cholinergic crisis = drug overdose needing less. Both cause weakness, but cholinergic crisis adds salivation, tearing, diarrhea, bradycardia |
| MG weakness | Normal exertion fatigue | MG weakness is caused by receptor loss at the NMJ and is a disease symptom; normal fatigue recovers quickly |
| Ocular MG (eyes only) | Generalized MG | Ocular symptoms alone are common early on; generalized MG affects bulbar, limb, and respiratory muscles with higher risk |
| ACh receptor antibodies | MuSK antibodies | Different antibody targets; most people are AChR-positive, a minority MuSK-positive — testing and treatment differ |
| "The drugs cure MG" | Symptomatic and immune-modulating treatment | AChE inhibitors relieve symptoms while the immune attack continues; immunosuppression modifies the disease but is not a cure |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine your muscles get a text message every time they need to move. In myasthenia gravis, the body's defense system puts sticky tape over the mail slot, so fewer messages get through. The more you use a muscle, the fewer open slots remain, and the muscle gets tired. Rest clears the slots. Medicines help by making each message last longer so it has a better chance of getting through.
Worked example
A nurse is caring for a 34-year-old person with myasthenia gravis admitted for a urinary tract infection. Over two days their eyelids have drooped more, their speech has become slurred in the evening, and they felt short of breath walking to the bathroom — a known infection (a classic flare trigger) plus worsening bulbar symptoms and new exertional breathlessness. The nurse stays with the person, elevates the head of the bed, checks respiratory effort and oxygen saturation, and notifies the provider and rapid-response team immediately rather than waiting for the next medication round. The provider assesses for myasthenic crisis, reviews the medication list, and adjusts the plan. The lesson: in MG, "a little more weakness" can be the first sign of a life-threatening emergency.
Key takeaways
- MG = autoimmune attack on the neuromuscular junction; most common target is the nicotinic acetylcholine receptor.
- Hallmark: fluctuating muscle weakness — worse with use (fatigability), better with rest, often worse later in the day.
- Classic first symptoms: ptosis and diplopia; bulbar symptoms signal higher risk; respiratory weakness signals crisis.
- Myasthenic crisis = disease flare → respiratory failure (needs more treatment); cholinergic crisis = drug overdose → weakness + muscarinic signs (needs less treatment). Never confuse the two.
- Cholinergic drugs (AChE inhibitors) boost the ACh signal — the symptomatic cornerstone; overdose causes cholinergic crisis.
- Flare triggers: infection, stress, surgery, and some medications — screen for them.
- Nursing anchors: respiratory assessment, swallow safety, medication timing, and teaching crisis warning signs.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What is the underlying mechanism of myasthenia gravis, and where does the attack occur?
Show answer
The immune system produces antibodies against proteins of the neuromuscular junction — most commonly the nicotinic acetylcholine receptor. Antibody binding reduces the number of functional receptors, so normal ACh release produces weaker muscle contraction.
What is fatigability, and why does it happen in MG?
Show answer
Weakness that worsens with repeated muscle use and improves with rest. Repeated nerve firing releases ACh that increasingly cannot be captured by the reduced number of receptors, so the signal weakens until rest allows partial recovery.
List three muscle groups commonly affected and one symptom for each.
Show answer
Eye muscles (ptosis, diplopia), bulbar muscles (slurred speech, difficulty chewing or swallowing), and limb/axial muscles (difficulty raising arms, climbing stairs).
A person with MG suddenly develops severe weakness, excess salivation, and diarrhea shortly after their usual medication. Is this more consistent with myasthenic crisis or cholinergic crisis? Why?
Show answer
Cholinergic crisis — weakness plus muscarinic signs (salivation, tearing, diarrhea, bradycardia) appearing in relation to medication. Myasthenic crisis is the disease flaring, typically with a trigger such as infection, and lacks these drug-toxicity signs. The two are managed in opposite directions; expert assessment determines the response.
Why does respiratory assessment matter so much in MG, and what signs would concern you?
Show answer
Because respiratory muscle weakness can progress to respiratory failure in myasthenic crisis. Concerning signs: breathlessness at rest or with minimal activity, weak or ineffective cough, rapid or shallow breathing. Any of these warrants immediate notification of the provider or rapid-response team.
What is the role of acetylcholinesterase inhibitors in MG, in mechanism terms only?
Show answer
They inhibit acetylcholinesterase, so ACh remains in the junction longer and has more opportunity to bind the remaining receptors. This strengthens contraction symptomatically; it does not stop the autoimmune attack.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Neuromuscular junction (NMJ)
- The synapse where a motor neuron signals a muscle fiber
- Acetylcholine (ACh)
- The neurotransmitter that triggers skeletal muscle contraction
- Fatigability
- Weakness that worsens with use and improves with rest
- Ptosis / Diplopia
- Drooping eyelid / double vision
- Myasthenic vs cholinergic crisis
- Disease flare vs medication overdose — both cause weakness
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.